| Crohn’s disease | Controls | |
| Patient data | ||
| No. of subjects | 65 | 11 |
| Mean age (years) | 31.4 (SD 11.4) | 52.7 (SD 17.7) |
| Sex, female, n | 35 (54%) | 8 (73%) |
| Ileal involvement, n | 65 (100%) | |
| Medical treatment | ||
| None, n | 37 (57%) | |
| Treatment, n | 28 (43%) | |
| Monotherapy, n | 13 | |
| Immunosuppression, n | 10 | |
| Steroids, n | 2 | |
| 5-ASA, n | 1 | |
| Combination therapy, n | 15 | |
| Sample data | ||
| No. of samples | 95 | 11 |
| Type | ||
| Resection, n | 21 (22%) | 0 (0%) |
| Biopsy, n | 74 (78%) | 11 (100%) |
| Histology | ||
| Non-inflamed, n | 51 (54%) | 11 (100%) |
| Inflamed, n | 44 (46%) | 0 (0%) |
| NOD2 status | ||
| Wild-type, n | 58 (61%) | 8 (73%) |
| Mutant*, n | 37 (39%) | 3 (27%) |
*Heterozygous or homozygous for any variant (R702W, G908R, 1007fs).